WOOG; Heinrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for WOOG; Heinrich.The latest application filed is for "stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies".

Company Profile

0.15.6

WOOG; Heinrich - Laudenbach DE
Woog; Heinrich - D-69514 Laudenbach DE
Woog; Heinrich - Ludwigshafen Rhine

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Lyophilized Pharmaceutical Preparations Of Monoclonal Or Polyclonal Antibodies App 20140248274 - KALLMEYER; Georg ; et al.	2014-09-04
Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies Grant 8,758,747 - Kallmeyer , et al. June 24, 2	2014-06-24
Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies App 20080286280 - KALLMEYER; Georg ; et al.	2008-11-20
Oral pharmaceutical formulation containing ibandronate App 20050089573 - Moeckel, Joern ; et al.	2005-04-28
Method of stabilizing biologically active substances Grant 6,689,755 - Gabel , et al. February 10, 2	2004-02-10
Stabilized carvedilol injection solution Grant 6,664,284 - Gruber , et al. December 16, 2	2003-12-16
Pharmaceutical composition containing diphosphonic acid or salt thereof Grant 6,627,221 - Gabel , et al. September 30, 2	2003-09-30
Stabilized carvedilol injection solution App 20020169199 - Gruber, Werner ; et al.	2002-11-14
Solid Instant-release Forms Of Administration And Process For Producing The Same App 20020122817 - GABEL, ROLF-DIETER ; et al.	2002-09-05
Process for making bisphosphonate compositions Grant 6,419,955 - Gabel , et al. July 16, 2	2002-07-16
Pharmaceutical composition containing diphosphonic acid or salt thereof App 20020006441 - Gabel, Rolf-Dieter ; et al.	2002-01-17
Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes Grant 6,303,113 - Woog , et al. October 16, 2	2001-10-16
Oral pharmaceutical preparation containing ibandronat Grant 6,143,326 - Mockel , et al. November 7, 2	2000-11-07
Pharmaceutical preparation containing metformin and a process for producing it Grant 5,955,106 - Moeckel , et al. September 21, 1	1999-09-21
Aqueous pharmaceutical preparations of G-CSF with a long shelf life Grant 5,919,757 - Michaelis , et al. July 6, 1	1999-07-06
Process for the production of multi-dose pharmaceutical preparations containing isolated or recombinantly produced human protein for infusion or injection purposes Grant 5,503,827 - Woog , et al. April 2, 1	1996-04-02
Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid Grant 5,324,749 - Woog , et al. June 28, 1	1994-06-28
Stabilized erythropoietin preparations Grant 4,992,419 - Woog , et al. February 12, 1	1991-02-12
Composition for a stable vein compatible injectable solution of torasemide process for the preparation and method of use Grant 4,861,786 - Demmer , et al. August 29, 1	1989-08-29
Compositions and method for diagnosing diseases of the pancreas Grant 3,917,812 - Woog , et al. November 4, 1	1975-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.